The Investment and Partnering conference for Life Sciences in the Nordics, Europe and the UK. Anglonordic is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other. With an established format of panel discussions, parallel technology and biotech investment rooms, plus 1:1 meetings, this conference provides exceptional value.

More information: https://www.anglonordiclifescience.com/

WHY ATTEND?

MEET decision makers at leading and upcoming drug discovery and technology companies from the UK and Nordic regions, and investment firms throughout Europe.

LEARN from major investment firms about the current status of European investment in life science technologies.

GAIN insights from experienced life science operators within the Anglo-Nordic space.

WHO WILL YOU MEET?

Exclusively selected attendees will represent the following key drivers of the European life sciences growth sector:

• CEOs, CSOs and Heads of Business Development from Emerging Life Science Companies in the Anglo-Nordic sphere and Continental Europe
• Decision-makers from Europe’s key Investor firms and Pharma companies
• Key Supporters of the Life Science Ecosystem in Europe

The 2022 event attracted an amazing total of 71 investment firms, with interests in a wide variety of technologies from small molecule discovery through protein technologies to AI applications and healthcare devices.